Concepedia

Mark Becker

MB

Statistics

Publications

8

Citations

914

H-Index

8

Active since

1996

Affiliations

Cleveland Clinic(Current)

Mark Becker is an author at Cleveland Clinic specializing in oncology, medicine, and cancer therapeutics.

Top concepts

Publications per year

1996–2021

8

Publications

8

Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma.

Susan J. Knox, Michael L. Goris, Kirk Trisler et al. · PubMed · 1996 · 332 citations

, , +14

Endoscopic Ultrasound Cannot Determine Suitability for Esophagectomy After Aggressive Chemoradiotherapy for Esophageal Cancer

Gregory Zuccaro, Thomas W. Rice, John R. Goldblum et al. · The American Journal of Gastroenterology · 1999 · 155 citations

, , +15

Treatment of hormone-refractory prostate cancer with 90Y-CYT-356 monoclonal antibody.

N Deb, M. Goris, Kirk Trisler et al. · PubMed · 1996 · 141 citations

, , +10

Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies

Daruka Mahadevan, E. Gabriela Chiorean, Wayne B. Harris et al. · European Journal of Cancer · 2012 · 131 citations

, , +8

Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma

David J. Adelstein, Thomas W. Rice, Mark Becker et al. · Cancer · 1997 · 113 citations · Full text

1–5 of 8